Candel Therapeutics CADL
NASDAQ CADL
$8.50 +0.13 (+1.55%)
As of: Oct 22, 2026 · 11:05 AM EDT

Candel Therapeutics (CADL) Long-Term Debt Repayments (2024 - 2025)

Updated

Analysis

Candel Therapeutics (CADL) Long-Term Debt Repayments (2024 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,171.06 Bn 1,139.65 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 634.89 Bn 553.42 Bn 17.26 Bn 1.00 Mn
3 AbbVie 503.32 Bn 476.44 Bn 12.70 Bn 2.00 Bn
4 Merck 377.44 Bn 331.82 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 303.91 Bn 267.90 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 267.03 Bn 240.72 Bn 12.86 Bn 2.46 Bn
7 Amgen 241.88 Bn 197.28 Bn 7.24 Bn -
8 Gilead Sciences 194.01 Bn 168.20 Bn 6.22 Bn 17.00 Mn
9 Pfizer 172.57 Bn 119.21 Bn 10.94 Bn -
10 Candel Therapeutics 633.82 Mn 124.88 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 4.23 Mn
Sep 30, 2025 2.50 Mn
Jun 30, 2025 2.50 Mn
Mar 31, 2025 2.50 Mn
Dec 31, 2024 2.50 Mn
Sep 30, 2024 2.50 Mn
Jun 30, 2024 2.50 Mn
Mar 31, 2024 1.67 Mn
API Access

Candel Therapeutics Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=CADL&period=max&api_key=YOUR_API_KEY